Coronavirus BRIEFING
Supported by Essilor

Crisis Response Tactics

MDs' One-Word Summary of Long COVID Progress: 'Frustration'

By Staff
Tuesday, June 11, 2024 8:02 AM Stuart Malcolm, MD, a primary care physician who practices in Oregon and Northern California, started seeing patients with long COVID early in the pandemic. Back then, he was frustrated by the obstacles and lack of standard diagnostic tests and treatments. Four years later, well, he still is.

COVID Shots Should Target Variants With JN.1 Lineage in 2024-25 Campaign, U.S. FDA Advisers Say

By Staff
Monday, June 10, 2024 8:02 AM Last week, advisers to the U.S. Food and Drug Administration unanimously voted in favor of recommending that COVID-19 vaccines for 2024-25 should target a strain within the lineage of the JN.1 variant that has been dominant this year.

'Unusual' Cancers Emerge After Pandemic

By Staff
Monday, June 10, 2024 6:09 AM Some "unusual" cancers emerged during the pandemic, but is COVID to blame? The uptick in aggressive, late-stage cancers since the dawn of the pandemic is confirmed by some early national data and a number of large cancer institutions.

Paxlovid Trial Flops for COVID Pneumonia

By Staff
Friday, June 7, 2024 6:09 AM In 2021, nirmatrelvir/ritonavir clearly decreased hospitalization and death among COVID-19 patients who had high risks of severe disease and who had not been vaccinated or previously infected. It's a drug that saved lives, and would have saved many more if the vaccines had not beaten it to the punch.

FDA Advisors Give a Hearty Thumbs Up to a COVID Vaccine Based on the JN.1 Strain

By Staff
Thursday, June 6, 2024 6:09 AM An FDA advisory committee voted unanimously, 16-0, Wednesday to recommend that the COVID-19 vaccines for the 2024-2025 season target the JN.1 strain of the virus.

The Push to Get More People Into Long COVID Studies

By Staff
Wednesday, June 5, 2024 8:02 AM When Ezra Spier was diagnosed with long COVID in late 2022, his main symptom, postexertional malaise, caused fatigue so severe that it forced him to quit his job as a technology entrepreneur. Since then, it's been a tough road for Spier, 37, who said he wouldn't wish his hellish condition on anyone.

Fauci Denies 'False Accusation' of COVID Origins Cover-Up

By Staff
Tuesday, June 4, 2024 6:09 AM House Republicans grilled Anthony Fauci, MD, former chief medical adviser to President Biden, during a contentious House hearing on Monday, but Fauci was adamant that accusations about his involvement in a cover-up of COVID-19's origins were false.

FDA Panel to Consider Which COVID Strain to Target in an Updated Vaccine

By Staff
Tuesday, June 4, 2024 6:09 AM The current predominant strain of COVID-19 should be a key consideration during the upcoming meeting of an FDA advisory committee tasked with making recommendations about the next COVID vaccine, agency staff said in a briefing document released Monday.

COVID Shot After Acute Coronary Syndrome Might Not Prevent Further Events

By Staff
Saturday, June 1, 2024 6:09 AM Vaccination for COVID-19 after an acute coronary syndrome (ACS) event was not associated with better cardiopulmonary outcomes or fewer major adverse cardiovascular events, according to a secondary analysis of the Brazilian VIP-ACS trial.

House Requests Fauci's Private COVID Emails

By Staff
Friday, May 31, 2024 6:09 AM Rep. Brad Wenstrup (R-Ohio), chair of the House subcommittee investigating the pandemic, has requested the private emails of Anthony Fauci, MD, relating to EcoHealth Alliance, the Wuhan Institute of Virology, and COVID's origins. Read more about it here.

COVID Shots Could Use Another Update, Study Suggests

By Staff
Thursday, May 30, 2024 6:09 AM The updated monovalent XBB.1.5 COVID-19 vaccines were effective against Omicron subvariants circulating during the most recent respiratory virus season, but their effectiveness waned over time, according to a brief report.

Not All COVID Patients Benefit From JAK Inhibitor

By Staff
Wednesday, May 29, 2024 8:02 AM People randomized to the Janus kinase (JAK) inhibitor baricitinib (Olumiant) to treat COVID-19 pneumonia in a clinical trial only saw a survival benefit if they had obesity, a post-hoc analysis found.

Study Demonstrates Changes in Brain Function After COVID

By Staff
Wednesday, May 29, 2024 8:02 AM A resting-state functional MRI study in China demonstrated changes in brain function in COVID survivors versus healthy controls. (Lancet Regional Health-Western Pacific)

Changing Entrenched Health Beliefs Is Not Impossible

By Staff
Friday, May 24, 2024 6:00 AM Turns out it’s not a Sisyphean task—or at least not impossible, like trying to roll a large boulder up a steep hill over and over again. Some people with deep-rooted beliefs on a wide range of health topics—from COVID vaccination to mental health stigma to foods including genetically modified organisms—could be persuaded to rethink their positions.

Maternal Mortality Soars in Brazil During the Pandemic

By Staff
Thursday, May 23, 2024 8:02 AM A recent Brazilian study yielded alarming data about the effect of the COVID-19 pandemic on maternal health. In 2020, the rate of maternal mortality was 40% higher than the average of the previous years. In 2021, there was a surge in the number of cases, and COVID-19 was responsible for 60% of maternal deaths that year.